BBS12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.106600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.465800E-01
Normal-vs-Stage2
9.661800E-01
Normal-vs-Stage3
4.429000E-01
Normal-vs-Stage4
6.769800E-01
Stage1-vs-Stage2
6.668200E-02
Stage1-vs-Stage3
9.955800E-02
Stage1-vs-Stage4
6.764800E-01
Stage2-vs-Stage3
1.962600E-01
Stage2-vs-Stage4
4.277800E-01
Stage3-vs-Stage4
1.681600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.303600E-01
Normal-vs-AfricanAmerican
8.226600E-01
Normal-vs-Asian
9.963000E-01
Caucasian-vs-AfricanAmerican
9.565400E-01
Caucasian-vs-Asian
6.791000E-01
AfricanAmerican-vs-Asian
7.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.730200E-01
Normal-vs-Female
7.384000E-01
Male-vs-Female
5.885000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.326200E-01
Normal-vs-Age(41-60Yrs)
4.632000E-01
Normal-vs-Age(61-80Yrs)
9.836600E-01
Normal-vs-Age(81-100Yrs)
7.280000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.945600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.888600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.045200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.065800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.255700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.172000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.244200E-01
Normal-vs-Daily Drinker
9.013200E-01
Normal-vs-Weekly Drinker
6.178600E-01
Normal-vs-Occasional Drinker
4.756200E-01
Normal-vs-Social Drinker
6.432400E-01
Non Drinker-vs-Daily Drinker
5.559600E-01
Non Drinker-vs-Weekly Drinker
8.892200E-01
Non Drinker-vs-Occasional Drinker
3.414000E-02
Non Drinker-vs-Social Drinker
1.380210E-01
Daily Drinker-vs-Weekly Drinker
5.786600E-01
Daily Drinker-vs-Occasional Drinker
7.952200E-02
Daily Drinker-vs-Social Drinker
2.583600E-01
Weekly Drinker-vs-Occasional Drinker
3.504500E-02
Weekly Drinker-vs-Social Drinker
1.354240E-01
Occasional Drinker-vs-Social Drinker
6.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.705600E-01
Normal-vs-Grade 2
7.195700E-03
Normal-vs-Grade 3
9.055500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.536800E-01
Grade 1-vs-Grade 3
3.509000E-01
Grade 1-vs-Grade 4
2.705600E-01
Grade 2-vs-Grade 3
5.073200E-01
Grade 2-vs-Grade 4
7.195700E-03
Grade 3-vs-Grade 4
9.055500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.442400E-01
Normal-vs-NonDiabetic
7.395800E-01
Diabetic-vs-NonDiabetic
2.049900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.629400E-01
Normal-vs-NoPancreatitis
8.211400E-01
Pancreatitis-vs-NoPancreatitis
4.558000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.397200E-01
Normal-vs-N1
9.089800E-01
N0-vs-N1
2.600200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.729600E-01
Normal-vs-TP53-NonMutant
6.539000E-01
TP53-Mutant-vs-TP53-NonMutant
3.833600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
